XML 64 R57.htm IDEA: XBRL DOCUMENT v3.25.1
Significant Agreements (Additional Information) (Details) - USD ($)
12 Months Ended
Nov. 15, 2024
Dec. 31, 2023
Dec. 21, 2023
Oct. 31, 2023
US        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Split Profits and Losses Percentage 40.00%      
AbbVie Option Agreement [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Non refundable payment     $ 5,000,000 $ 1,000,000
Allowable Expenses Reimbursed Percenage 60.00%      
Upfront Cash Payment $ 100,000,000      
Milestone payments $ 100,000,000      
Split Profits and Losses Percentage 60.00%      
Revenues   $ 0    
Deferred collaboration revenue   6,000,000    
Transaction price   $ 6,000,000    
AbbVie Option Agreement [Member] | Maximum [Member]        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]        
Milestone payments $ 300,000,000